ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 8 filers reported holding ODONATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $115,000 | -61.8% | 85,538 | -17.3% | 0.00% | – |
| Q3 2021 | $301,000 | -31.1% | 103,403 | -17.4% | 0.00% | – |
| Q2 2021 | $437,000 | -66.5% | 125,138 | -67.2% | 0.00% | – |
| Q1 2021 | $1,303,000 | -74.2% | 381,118 | +45.0% | 0.00% | – |
| Q4 2020 | $5,048,000 | +51.1% | 262,916 | +5.7% | 0.00% | – |
| Q3 2020 | $3,340,000 | -68.1% | 248,662 | +0.6% | 0.00% | -100.0% |
| Q2 2020 | $10,466,000 | +72.7% | 247,181 | +12.6% | 0.00% | 0.0% |
| Q1 2020 | $6,059,000 | -22.5% | 219,465 | -8.9% | 0.00% | 0.0% |
| Q4 2019 | $7,815,000 | +45.7% | 240,818 | +16.8% | 0.00% | – |
| Q3 2019 | $5,365,000 | +3.9% | 206,111 | +46.4% | 0.00% | – |
| Q2 2019 | $5,165,000 | +113.6% | 140,767 | +28.7% | 0.00% | – |
| Q1 2019 | $2,418,000 | +62.6% | 109,361 | +3.5% | 0.00% | – |
| Q4 2018 | $1,487,000 | -34.1% | 105,634 | -9.2% | 0.00% | – |
| Q3 2018 | $2,258,000 | +3.9% | 116,291 | +18.1% | 0.00% | – |
| Q2 2018 | $2,173,000 | +12.8% | 98,490 | +8.3% | 0.00% | – |
| Q1 2018 | $1,926,000 | – | 90,957 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $297,880,000 | 45.48% |
| Boxer Capital, LLC | 5,607,086 | $107,656,000 | 3.46% |
| Samsara BioCapital, LLC | 815,421 | $15,656,000 | 1.57% |
| GSA CAPITAL PARTNERS LLP | 148,148 | $2,844,000 | 0.46% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,211,728 | $23,265,000 | 0.38% |
| RTW INVESTMENTS, LP | 1,000,139 | $19,203,000 | 0.32% |
| Sio Capital Management, LLC | 75,500 | $1,450,000 | 0.30% |
| AlphaCentric Advisors LLC | 29,594 | $568,000 | 0.24% |
| Birchview Capital, LP | 20,000 | $384,000 | 0.22% |
| Aristides Capital LLC | 33,226 | $638,000 | 0.22% |